Technical Description
The invention presents a novel substituted quinazolinone compound for Alzheimer’s treatment, detailing a synthesis method involving a benzoic acid intermediate and metal-free cyclization, followed by C–N bonding via Buckwald Hartwig reaction.
Problems Addressed
- Limited Substitution
- Expensive Processes
- Diversity Constrained
- Metal-based Cyclization
Tech Features
- Substituted Heterocyclic Compound
- Functional Group Substitution
- Purified with Column Chromatographic
- Mild Reaction Conditions
- Eco-Friendly Reagents
- Enhanced Barrier Penetration
- Cost-effective
Target Audience
- Pharmaceutical Industry
- Biomedical Sector
- Elder Care Centers
- Healthcare Sector
Tech ID: P27-1924 TRL 4 Patent Status: Granted Available For Exclusive and Non-exclusive License
